|
LHCb Collaboration(Aaij, R. et al), Martinez-Vidal, F., Oyanguren, A., Ruiz Valls, P., & Sanchez Mayordomo, C. (2015). Study of B- -> DK-pi(+)pi(-) and B- -> D pi(-)pi(+)pi(-) decays and determination of the CKM angle gamma. Phys. Rev. D, 92(11), 112005–20pp.
Abstract: We report a study of the suppressed B- -> DK-pi(+)pi(-) and favored B- -> D pi(-)pi(+)pi(-) decays, where the neutral D meson is detected through its decays to the K--/+pi(+/-) and CP -even K+K- and pi(+)pi(-) final states. The measurement is carried out using a proton-proton collision data sample collected by the LHCb experiment, corresponding to an integrated luminosity of 3.0 fb(-1). We observe the first significant signals in the CP – even final states of the D meson for both the suppressed B- -> DK-pi(+)pi(-) and favored B- -> D pi(-)pi(+)pi(-) modes, as well as in the doubly Cabibbo suppressed D -> K+pi(-) final state of the B- -> D pi(-)pi(+)pi(-) decay. Evidence for the suppressed decay B- -> DK-pi(+)pi(-), with D -> K+pi(-), is also presented. From the observed yields in the B- -> DK-pi(+)pi(-), B- -> D pi(-)pi(+)pi(-) and their charge conjugate decay modes, the most probable value of the weak phase gamma corresponds to gamma = (74(-19)(+20))degrees. This is one of the most precise single-measurement determinations of gamma to date.
|
|
|
LHCb Collaboration(Aaij, R. et al), Martinez-Vidal, F., Oyanguren, A., Ruiz Valls, P., & Sanchez Mayordomo, C. (2015). Search for long-lived heavy charged particles using a ring imaging Cherenkov technique at LHCb. Eur. Phys. J. C, 75(12), 595–14pp.
Abstract: A search is performed for heavy long-lived charged particles using 3.0 fb(-1) of proton-proton collisions collected at root s = 7 and 8 TeV with the LHCb detector. The search is mainly based on the response of the ring imaging Cherenkov detectors to distinguish the heavy, slow-moving particles from muons. No evidence is found for the production of such long-lived states. The results are expressed as limits on the Drell-Yan production of pairs of long-lived particles, with both particles in the LHCb pseudorapidity acceptance, 1.8 < eta < 4.9. The mass-dependent cross-section upper limits are in the range 2-4 fb (at 95 % CL) for masses between 14 and 309 GeV/c(2).
|
|
|
ATLAS Collaboration(Aad, G. et al), Alvarez Piqueras, D., Cabrera Urban, S., Castillo Gimenez, V., Costa, M. J., Fernandez Martinez, P., et al. (2015). Constraints on new phenomena via Higgs boson couplings and invisible decays with the ATLAS detector. J. High Energy Phys., 11(11), 206–52pp.
Abstract: The ATLAS experiment at the LHC has measured the Higgs boson couplings and mass, and searched for invisible Higgs boson decays, using multiple production and decay channels with up to 4.7 fb(-1) of pp collision data at root S = 7 TeV and 20.3 fb(-1) at root s = 8 TeV. In the current study, the measured production and decay rates of the observed Higgs boson in the gamma gamma, ZZ, WW, Z gamma, bb, tau tau, and μμdecay channels, along with results from the associated production of a Higgs boson with a top-quark pair, are used to probe the scaling of the couplings with mass. Limits are set on parameters in extensions of the Standard Model including a composite Higgs boson, an additional electroweak singlet, and two-Higgs-doublet models. Together with the measured mass of the scalar Higgs boson in the gamma gamma and ZZ decay modes, a lower limit is set on the pseudoscalar Higgs boson mass of m(A) > 370 GeV in the “hMSSM” simplified Minimal Supersymmetric Standard Model. Results from direct searches for heavy Higgs bosons are also interpreted in the hMSSM. Direct searches for invisible Higgs boson decays in the vector-boson fusion and associated production of a Higgs boson with W/Z (Z -> ll, W/Z -> jj) modes are statistically combined to set an upper limit on the Higgs boson invisible branching ratio of 0.25. The use of the measured visible decay rates in a more general coupling fit improves the upper limit to 0.23, constraining a Higgs portal model of dark matter.
|
|
|
Dorado-Morales, P., Vilanova, C., Pena-Garay, C., Marti, J. M., & Porcar, M. (2015). Unveiling Bacterial Interactions through Multidimensional Scaling and Dynamics Modeling. Sci Rep, 5, 18396–6pp.
Abstract: We propose a new strategy to identify and visualize bacterial consortia by conducting replicated culturing of environmental samples coupled with high-throughput sequencing and multidimensional scaling analysis, followed by identification of bacteria-bacteria correlations and interactions. We conducted a proof of concept assay with pine-tree resin-based media in ten replicates, which allowed detecting and visualizing dynamical bacterial associations in the form of statistically significant and yet biologically relevant bacterial consortia.
|
|
|
Palomo, R., Pujades, M. C., Gimeno-Olmos, J., Carmona, V., Lliso, F., Candela-Juan, C., et al. (2015). Evaluation of lens absorbed dose with Cone Beam IGRT procedures. J. Radiol. Prot., 35(4), N33–N41.
Abstract: The purpose of this work is to evaluate the absorbed dose to the eye lenses due to the cone beam computed tomography (CBCT) system used to accurately position the patient during head-and-neck image guided procedures. The on-board imaging (OBI) systems (v. 1.5) of Clinac iX and TrueBeam (Varian) accelerators were used to evaluate the imparted dose to the eye lenses and some additional points of the head. All CBCT scans were acquired with the Standard-Dose Head protocol from Varian. Doses were measured using thermoluminescence dosimeters (TLDs) placed in an anthropomorphic phantom. TLDs were calibrated at the beam quality used to reduce their energy dependence. Average dose to the lens due to the OBI systems of the Clinac iX and the TrueBeam were 0.71 +/- 0.07 mGy/CBCT and 0.70 +/- 0.08 mGy/CBCT, respectively. The extra absorbed dose received by the eye lenses due to one CBCT acquisition with the studied protocol is far below the 500 mGy threshold established by ICRP for cataract formation (ICRP 2011 Statement on Tissue Reactions). However, the incremental effect of several CBCT acquisitions during the whole treatment should be taken into account.
|
|